Atherosclerosis  >>  pioglitazone  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00598013: Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes

Completed
N/A
83
RoW
Pioglitazone
Yonsei University
Kidney Transplantation, Insulin Resistance, Atherosclerosis
11/07
11/07
NCT00722631: Anti-Inflammatory Effects of Pioglitazone

Completed
N/A
70
Japan
Pioglitazone, CAS number: 111025-46-8, ATC code: A10BG03, Glimepiride, CAS number: 93479-97-1, ATC code: A10BB12
Kurume University
Impaired Glucose Tolerance, Type 2 Diabetes Mellitus, Atherosclerosis
04/09
04/12
NCT00745914: Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients

Completed
N/A
22
RoW
Pioglitazone, Actos, Placebo comparator, Placebo
The University of Hong Kong
Endstage Renal Disease, Diabetes
09/13
12/13

Download Options